CDI teams should focus on ensuring narrative encounter notes explicitly support each diagnosis code
For skeletal muscle, heart, or corneal models, TB-500 has stronger coverage with several independent teams (Spurney 2010, Bock-Marquette 2004, Sosne 2011)
Meloni M, Giurato L, Monge L, Miranda C, Scatena A, Ragghianti B, Silverii GA, Vermigli C, De Cassai A, Volpe A, Tramonta R, Medea G, Bordieri C, Falcone M, Stefanon L, Bernetti A, Cappella C, Gargiulo M, Lorenzoni W, Scevola G, Stabile E, Da Ros R, Murdolo G, Bianchini E, Gaggia F, Gauna C, Romeo F, Apicella M, Mantuano M, Monami M, Uccioli L
CJC-1295/Ipamorelin is not an anabolic steroid
GLP-1 Market Expands Beyond Obesity Investors increasingly view GLP-1 drugs as a broader metabolic-health platform extending beyond obesity and diabetes into areas such as sleep apnea, kidney disease, cardiovascular risk, liver disease and addiction treatment